For the year ending 2025-12-31, INGN had -$12,397K decrease in cash & cash equivalents over the period. -$13,739K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -22,747 |
| Depreciation and amortization | 20,659 |
| Loss on rental units and other assets | -3,208 |
| Loss (gain) on sale of former rental assets | -57 |
| Provision for sales revenue returns and doubtful accounts | 6,351 |
| Provision for inventory losses | 822 |
| Loss on purchase commitments | 433 |
| Stock-based compensation expense | 8,014 |
| Deferred income taxes | -1,100 |
| Accounts receivable | 14,624 |
| Inventories | 3,210 |
| Prepaid expenses and other current assets | -1,298 |
| Operating lease right-of-use asset | -3,169 |
| Other noncurrent assets | -1,762 |
| Accounts payable and accrued expenses | 5,598 |
| Accrued payroll | -6,750 |
| Warranty reserve | 2,224 |
| Deferred revenue | -3,295 |
| Income tax payable | 46 |
| Operating lease liability | -3,309 |
| Earnout liability | -9,822 |
| Net cash (used in) provided by operating activities | -11,216 |
| Purchases of available-for-sale securities | 29,829 |
| Maturities of available-for-sale securities | 14,003 |
| Investment in property and equipment | 2,523 |
| Production and purchase of rental equipment | 7,860 |
| Net cash used in investing activities | -26,209 |
| Proceeds from employee stock purchases | 971 |
| Payment of employment taxes related to release of restricted stock | 821 |
| Payments of accrued earnout | 3,178 |
| Proceeds from issuance of common stock from securities purchase agreement | 27,210 |
| Net cash provided by financing activities | 24,182 |
| Effect of exchange rates on cash | 846 |
| Net decrease in cash, cash equivalents and restricted cash | -12,397 |
| Cash, cash equivalents and restricted cash, beginning of period | 117,415 |
| Cash, cash equivalents and restricted cash, end of period | 105,018 |
Inogen Inc (INGN)
Inogen Inc (INGN)